Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
Tickers
BIIB
NEWS
UCBJF
UCBJY
Tags
News
Briefs
General
From
Benzinga
Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
November 18, 2024
Tickers
BIIB
ESALY
NEWS
SHL
Tags
Market News
Analyst Ratings
SHL
From
Benzinga
This Biogen Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
November 18, 2024
Tickers
BFAM
BIIB
CW
FTV
Tags
Trading Ideas
MATX
Benzinga
From
Benzinga
Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
November 15, 2024
Tickers
AGYS
AMAT
BIIB
DIS
Tags
SEDG
AMAT
TSEM
From
Benzinga
Peeling Back The Layers: Exploring Biogen Through Analyst Insights
November 14, 2024
Tickers
BIIB
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Evaluating Biogen: Insights From 17 Financial Analysts
November 04, 2024
Tickers
BIIB
Tags
Market News
Analyst Ratings
BZI/AAR
From
Benzinga
Biogen Analysts Slash Their Forecasts After Q3 Results
October 31, 2024
Tickers
BIIB
NEWS
Tags
News
Price Target
Earnings
From
Benzinga
This Kraft Heinz Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
October 31, 2024
Tickers
ARM
BIIB
EAT
KHC
Tags
Benzinga
ARM
Trading Ideas
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
Trading Ideas
Analyst Ratings
BMY
From
Benzinga
Biogen (BIIB) Q3 2024 Earnings Call Transcript
October 30, 2024
Tickers
BIIB
Tags
Market News
BIIB
Recent Press Releases
From
Motley Fool
Biogen's Q3 Profit Beats Expectations On Lower Multiple Sclerosis Revenues But New Products Offset Losses, Raises Profit Outlook
October 30, 2024
Tickers
BIIB
NEWS
Tags
Earnings
News
Briefs
From
Benzinga
This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock
October 23, 2024
Tickers
BIIB
JNJ
LLY
Tags
Recent Press Releases
BIIB
LLY
From
Motley Fool
Looking Into Biogen's Recent Short Interest
October 22, 2024
Tickers
BIIB
Tags
Benzinga
BIIB
Trading Ideas
From
Benzinga
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce
October 17, 2024
Tickers
BIIB
NEWS
SAGE
Tags
General
Management
SAGE
From
Benzinga
Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock
October 16, 2024
Tickers
BIIB
LRMR
NEWS
PTC
Tags
Health Care
BIIB
Biotech
From
Benzinga
Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
October 14, 2024
Tickers
BIIB
ESALY
LLY
NEWS
Tags
Benzinga
LLY
Market News
From
Benzinga
The Latest Analyst Ratings For Biogen
October 10, 2024
Tickers
BIIB
Tags
BIIB
Benzinga
BZI/AAR
From
Benzinga
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
October 08, 2024
Tickers
BIIB
NEWS
SAGE
Tags
Market News
Trading Ideas
Benzinga
From
Benzinga
Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year
October 07, 2024
Tickers
BIIB
NEWS
RHHBY
SRRK
Tags
Stories That Matter
Top Stories
Movers
From
Benzinga
Looking Into Biogen's Recent Short Interest
October 03, 2024
Tickers
BIIB
Tags
Short Ideas
BZI/SHORTHIST
Market News
From
Benzinga
1 Unstoppable Growth Stock Heading to $2 Trillion by 2030
September 28, 2024
Tickers
BIIB
LLY
Tags
Market News
LLY
BIIB
From
Motley Fool
Biogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
September 26, 2024
Tickers
BIIB
NEWS
SAGE
Tags
Briefs
News
Contracts
From
Benzinga
Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial
September 24, 2024
Tickers
BIIB
NEWS
UCBJF
UCBJY
Tags
Stories That Matter
Top Stories
News
From
Benzinga
Forecasting The Future: 20 Analyst Projections For Biogen
September 23, 2024
Tickers
BIIB
Tags
Market News
Analyst Ratings
BZI/AAR
From
Benzinga
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
September 09, 2024
Tickers
BIIB
LLY
NEWS
NVDA
Tags
Lucas Montarce
Markets
NVDA
From
Benzinga
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
September 09, 2024
Tickers
BIIB
BMY
NEWS
Tags
Politics
Edge Project
Shivdeep Dhaliwal
From
Benzinga
Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges
September 09, 2024
Tickers
BIIB
ESALY
NEWS
Tags
General
Alzheime's
News
From
Benzinga
Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder
September 04, 2024
Tickers
BIIB
NEWS
Tags
Biotech
Large Cap
News
From
Benzinga
Key Takeaways From Biogen Analyst Ratings
September 04, 2024
Tickers
BIIB
Tags
BZI/AAR
Benzinga
BIIB
From
Benzinga
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
August 31, 2024
Tickers
BIIB
LLY
NVO
Tags
Recent Press Releases
BIIB
NVO
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.